UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of
The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): April 6, 1999
BMJ Medical Management, Inc.
----------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 001-13785 65-0676079 .
-------- --------- ---------- -
(State or Other Jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
4800 North Federal Highway, Suite 101E, Boca Raton, Florida 33431
- ----------------------------------------------------------- -----
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (561) 391-1311
<PAGE>
Item 4. Change in Registrant's Certifying Accountant.
On March 30, 1999, Ernst & Young LLP resigned as the independent
auditor of BMJ Medical Management, Inc. (the "Company") and its subsidiaries,
effective as of that date.
Ernst and Young LLP's reports on the financial statements for each of
the last two years did not contain any adverse opinion or disclaimer of opinion,
and were neither qualified or modified as to uncertainty, audit scope or
accounting principles. During the last two fiscal years and subsequent interim
period to the date hereof, there have been no disagreements between the Company
and Ernst & Young LLP on any matters of accounting principles or practices,
financial statement disclosure or auditing scope or procedures which, if not
resolved to the satisfaction of Ernst & Young LLP, would have caused it to make
reference to the matter in the auditor's report.
In connection with the filing of this Form 8-K, Ernst & Young LLP was
provided with a copy of this disclosure and was requested by the Company to
furnish to the Company a letter addressed to the Commission stating whether
Ernst & Young LLP agrees with the above statements. A copy of Ernst & Young
LLP's letter to the Commission is attached hereto as Exhibit 16 to this Form
8-K.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
16 Letter dated April 6, 1999, delivered by
Ernst & Young LLP to the Securities
and Exchange Commission.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BMJ Medical Management, Inc.
Dated: April 6, 1999 By: /s/ DAVID H.FATER
-----------------
David H. Fater
Executive Vice-President and
Chief Financial Officer
3
April 6, 1999
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549
Gentlemen:
We have read Item 4 of Form 8-K dated April 6, 1999, of BMJ Medical Management,
Inc. and are in agreement with the statements contained in the first, second and
third paragraphs on page 2 therein. We have no basis to agree or disagree with
other statements of the registrant contained therein.
Very truly yours,
/s/ Ernst & Young
